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Abstract: Synergisms between pharmacological agents and endogenous neurotransmitters are familiar and frequent. The present review 
describes the experimental evidence for interactions between neuropharmacological compounds and the classes of weak magnetic fields 
that might be encountered in our daily environments. Whereas drugs mediate their effects through specific spatial (molecular) structures, 
magnetic fields mediate their effects through specific temporal patterns. Very weak (microT range) physiologically-patterned magnetic 
fields synergistically interact with drugs to strongly potentiate effects that have classically involved opiate, cholinergic, dopaminergic, se-
rotonergic, and nitric oxide pathways. The combinations of the appropriately patterned magnetic fields and specific drugs can evoke 
changes that are several times larger than those evoked by the drugs alone. These novel synergisms provide a challenge for a future 
within an electromagnetic, technological world. They may also reveal fundamental, common physical mechanisms by which magnetic 
fields and chemical reactions affect the organism from the level of fundamental particles to the entire living system.  
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I. INTRODUCTION  
  Synergisms, potentiations, and summations between pharma-
cological agents or endogenous neurochemistry are phenomena that 
challenge contemporary models and mechanisms and increase the 
risk of adverse effects from multiple medications. Within the last 
century and in particular during the last twenty years there have 
been increasingly prevalent and pervasive stimuli that have the 
potential to interact with endogenous neurochemistry and pharma-
cological treatments. These stimuli are environmental electromag-
netic fields (MF) whose temporal patterns and frequencies overlap 
with those generated by living systems. This review examines the 
availableliteratureoninteractionsbetween physiologically-patterned 
MF and pharmacological agents with particular emphasis on the 
receptors and neurotransmitters through which these effects might 
be mediated.  
  The ubiquity of magnetic fields with extraordinarily complex 
and potentially physiologically-patterned shapes and intensities is a 
consequence of a synthetic environment that has been hereto unex-
perienced by living systems. In addition to the myriad of time-
varying patterns generated directly by electronic devices such as 
computers, light sources, and innumerable household appliances, 
there are the emergent fields from the rapid growth of communica-
tion systems. Although the carrier frequencies are within the GHz 
range, extraordinary numbers of different signals within this range 
propagated simultaneously can create a secondary matrix composed 
of the "beats" or differences between these frequencies. These are 
within the range generated by the brain.  
  MF as opposed to electric fields have the capacity to penetrate 
the volume of matter that defines living systems. Whereas the 
availability of exogenously applied chemicals to the intracellular 
environment is contingent upon vasculature and its multiple imped-
ances and filters, appropriately patterned MF have the potential to 
penetrate homogenously through body space or "focus" upon struc-
tures or regions whose intrinsic cohesive temporal patterns of neu-
roelectrical and electromagnetic activity are systematically related 
to their own. Whereas models for potential mechanisms were once 
relegated almost exclusively to some variant of the concept that an 
induced electric field (and hence current depending upon the local 
conductivity of the medium) is associated with a changing magnetic 
field, there are now multiple tested and verified alternative explana-
tions that include the concepts of resonance.  
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  Intensity-dependence in MF research has been considered the 
powerfulanalogueof dose-dependence in pharmacological research. 
Non-linearity in both domains has been accepted and the presence 
of "bands" or "windows" [1] of maximum biological or biochemical 
effect as a function of magnetic field intensity or drug concentration 
are clearly demonstrable [37, 80]. Most conceptual arguments rest 
upon the assumed magnitude for thresholds. Whereas the empirical 
observations that a plethora of "maximum" responses that occupy a 
range from very low (femtomole) to very high (millimole) concen-
trations of ligands in pharmacology have been resolved by the con-
cept of receptor subtypes, the equivalent has not been seriously 
considered in magnetobiology and magnetochemistry. Yet reliable 
biological effects have been reported, depending upon the duration 
of exposure and the complexity of the magnetic field, with intensi-
ties between 1 nanoT and 100 microT (0.1 milliT). This range ex-
tends several orders of magnitude and includes most of the values 
generated within the modern environment.  
  The interactions between maximally effective applied MF (due 
to intentional design or by statistical occurrence) and receptor sys-
tems stimulated by pharmacological agents could be as powerful as 
the most potent chemical synergism. In pharmacology, the receptor-
agonist interaction within the cell surface ultimately results in a 
series of intracellular signaling pathways that mediate "the informa-
tion" afforded by the temporal and spatial patterns of the seques-
tered neurotransmitter. If this "information," which determines the 
activity and function of the cell, is a series of frequency-modulated 
or phase-modulated electromagnetic patterns mediated by calcium 
waves and related phenomena, then direct interactions with applied 
MF could occur.  
  Undertaking the pragmatic development and theoretical under-
standing of synergisms between weak magnetic fields and pharma-
cological agents requires an appreciation for complexity. Structure 
dictates function. Whereas the functions of molecules within bio-
logical space are determined by their spatial organization, the func-
tions of weak, physiologically-patterned MF within biological 
space are determined by their temporal organization. From the per-
spective of an optimal parsimony, every molecular structure and its 
interaction with receptors should have an equivalent temporal pat-
tern that can be simulated by the appropriately applied MF.  
  Until recently the temporal patterns of MF have emphasized the 
symmetry and simplicity of sinusoidal waves or square waves. 
Usually intensities (measured in Tesla, T) in the order of milliT or 
greater have been required to produce reliable effects with these 
field strengths. On the other hand complex, asymmetrical and 
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many times less (microT to picoT). While large, such ranges are not 
unusual in neuropharmacology. Whereas extraordinary large 
amounts of water, a very simple structure, may be required to elicit 
biological effects, an extremely small amount of a protein, a very 
complex structure, may be required to produce the same magnitude 
of effect.  
  As the frequency of the applied MF determines its physical 
properties, MF falling within related frequency bands of the elec-
tromagnetic spectrum demonstrate some homology in their effects. 
It is therefore practical to group MF falling within a frequency band 
into a singular category with distinct characteristics. Here, these 
categories are defined as extremely low frequency (ELF-MF of <
300 Hz), very high frequency (VHF-MF of 300 MHz – 300 GHz) 
and static (SMF of effectively 0 Hz or "static"). As investigations 
into MF focus on the discrete frequencies and frequency bands 
encountered in occupational and home settings, only a restricted 
portion of frequencies are explored and here analyzed.  
II. NEUROTRANSMITTER SYSTEMS AND MF  
a. Opiates  
  Changes in opiate-mediated behaviours such as nociception are 
a classic response to ELF- and VHF-MF exposure and have been 
characterized in many species, including mice [22, 23, 49, 50, 57, 
115, 121, 129, 151], rats [6, 25, 48, 85, 117, 162] and the land snail, 
Cepaea nemoralis [56, 58, 113, 114, 160, 161, 167]. SMF may 
have nociceptive and potentially analgesic effects as well [28] but 
these responses have not been subjected to the experimental rigor as 
those for ELF- and VHF-MF have been. Alteration in nociception is 
a robust effect from MF and has obvious therapeutic advantage in 
the treatment of pain. Not surprisingly, MF-induced analgesia has 
inspired a large corpus of literature. Collectively, the literature 
strongly supports that endogenous opiates are among the early ef-
fectors of MF-induced analgesia and many other exposure effects, 
including neurochemical interactions.  
  The effect of MF exposure on nociception is variable and de-
pends on the field used and species studied. Both augmentation and 
retardation of analgesia have been demonstrated with simple and 
complex MF of intermediate intensity (microT to milliT). This 
bidirectional effect on analgesia may reflect a complex influence on 
the opiate system. A number of external co-determinants may act in 
these studies, including levels of light [58, 114]. Though there is a 
conservation of the structure of the opiate system with evolution 
[158], differential sensitivity to analgesia-inducing MF exists be-
tween species. Shupak and colleagues [151] found no additive an-
algesic effect between morphine and pulsed MF treatment in CF1 
mice, in contrast with past results in Cepaea nemoralis shown by 
Thomas and colleagues. Accordingly, the effect sizes also vary 
between species, with more robust, strong effects being noted in 
Cepaea nemoralis (50-80%) and mice and weaker effects being 
noted in rats and humans (10-30%). Effect size is defined here as 
the amount of variance in the dependent variable explained by the 
treatment (independent variable) and is equivalent to r-squared 
values for correlations.  
  A specific central opiate receptor population is likely involved 
in all these responses. In exploring the mechanism of this phe-
nomenon, Thomas and others [160] utilized various opiate receptor 
antagonists to identify the contribution of each subtype of opiate 
receptor to analgesia. Inhibition of analgesia by physiologically-
patterned, frequency-modulated, pulsed MF was seen with the non-
specific antagonist naloxone, mu-opiate receptor antagonists nalox-
azine and beta-funaltrexamine and delta-opiate antagonists naltrin-
dole-5'-isothiocyanate and ICI 174,864. Antagonism of kappa-
opiate receptors with nor-binaltorphimine had no effect. In a man-
ner consistent with opiate tolerance, decreases in effectiveness and 
cross-tolerance of MF-induced analgesia to other opiate agonists 
developed with repeated exposure [161]. This finding reinforces the 
conclusion that opiates and MF share a pharmacological substrate 
within the nervous system. In later work with rats, Lai and Carino 
[66] showed that the decreases in the cholinergic activity [67] of the 
hippocampus and frontal cortex that occurred with exposure to a 60 
Hz field also involved mu and delta-opiate receptors.  
  These experiments showed a role of opiates in simple and 
pulsed ELF-MF response, but opiate-like effects induced by VHF-
MF and microwave (MW) fields also exist and have been character-
ized for more then a decade. Unfortunately, examples have been 
sparse in recent literature. Pulsed, 2.45 GHz (2 micros pulse width, 
500 pulses/s) MW, similar to those emitted by microwave appli-
ances, have been shown to have effects similar to stress-induced 
states [71] that are sensitive to pharmacological modulation of opi-
ate receptors [65, 69, 70]. Pretreatment with naltrexone reversed 
many of the effects of MW exposure, including those on choliner-
gic activity in the hippocampus and frontal cortex [70]. Specific 
receptor subtypes involved in MW responses have been implicated. 
Inhibition of the mu-opiate receptors with betafunaltrexamine in the 
septal nucleus blocked the cholinergic effect of MW [72]. Cho-
linergic changes within the frontal cortex also resulted from MW 
exposure; however they were non-responsive to opiate pharmacol-
ogy and may be dissociated from the central opiate system [69].  
  The effects of other VHF-MF fields on opiate activity parallel 
those of ELF-MF. The application of VHF-MF to the skin, which is 
the basis of millimeter-wave therapy (MWT), may be effective in 
treating pain [132, 168] and possibly cancers such as melanoma 
[121]. MWT effects are also highly consistent with and sensitive to 
opiate modulation. In mice, naloxone pretreatment blocked the 
analgesia [129], the inhibition of the scratching caused by prurito-
genic agents [130], and the lengthening (by 50%) of the anaesthesia 
evoked by either chloral hydrate (450 mg/kg) or ketamine (80 
mg/kg) [131] with MWT. While central opiates appear involved, 
research has also demonstrated a striking role of the peripheral 
nervous system as well. Innervation density of free nerve endings 
within the exposed area determines the effectiveness of MWT [123] 
and transection of the sciatic nerve abolishes the beneficial effects 
[122]. Other factors, including the biochemical composition of the 
tissue, may affect absorption and response [34]. With MWT, central 
opiates may act in concert with other peripheral magnetosensitive 
agents to produce the therapeutic outcome.  
b. Serotonin (5-HT)  
  Many of the psychological effects of MF, such as the reduction 
in anxiety and depression seen with repetitive transcranial magnetic 
stimulation (rTMS) treatment [10, 53, 54] and with ELF-MF [5], 
are consistent with serotonin (5-hydroxytryptamine or 5-HT) modu-
lation. As well as having unique cognitive effects, 5-HT modulation 
with MF may contribute to MF-induced analgesia indirectly. Here 
the relevant effects on 5-HT from ELF-MF and SMF applications, 
along with the most recent effects identified in rTMS, are dis-
cussed.  
  There are ties between MF-induced 5-HT modulation and MF-
induced behavioral changes. Recently, using a 55.6 Hz, 8.1 milliT 
MF, Bao and colleagues [6] showed an increase in brainstem 5-HT 
as well as hypothalamic beta-endorphin and substance P in the rat 
following exposure for 4 days at 6 hr per day. Analgesia exhibited a 
similar time course and was found on days 3 and 4 only. The con-
spicuous increase in 5-HT and other biochemical markers was ab-
sent past a seventh day of exposure, but the mechanisms of this 
adaptation were difficult to discern. Down-regulation of 5-HT2
receptors is known to occur in the frontal cortex with MF exposure 
[10] and is accompanied by an up-regulation in beta-adrenergic 
receptors. Weak, pulsed ELF-MF may be useful in reversing the 
progressive neuronal atrophy of multiple sclerosis [141] by affect-
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  In the above studies, the conferred change was short-term and 
required acute exposure (approximately 1 ksec to 20 ksec). Rajen-
dra and colleagues found no effects on 5-HT in chick embryos ex-
posed for as long as 15 days to a 50 Hz MF [124] while Margonato 
and others showed no 5-HT effects from a 50 Hz MF applied for 
22h/day for 32 weeks [84]. The intensities for both experiments 
ranged between 5 microT to 0.1 milliT. Significant alterations in 
hypothalamic 5-HT have been observed in male rats exposed to a 
0.1 mT SMF for 1 month [14] but when the exposure period was 
extended to 4 months no changes were found. No effects have been 
found with exposure to stronger SMF (80 milliT and 7 T) [64]. In 
eliciting 5-HT effects, applying the optimal temporal pattern ap-
pears more important then the field's intensity. As is found in stud-
ies examining the influences of MF on opiate-mediated behaviour, 
measurements after long exposure periods usually yield negative 
findings. The "window of influence" [1] for MF upon 5-HT appears 
short.  
  The mechanisms of adaptation by the 5-HT system during ex-
posures to MF have only begun to be uncovered. Desensitization of 
the 5-HT1B receptor following exposure to a 50 Hz, 2.5 milliT MF 
has been noted [86]. Massot et al. [86] hypothesized this change 
was a primary source of the clinically beneficial effects of rTMS 
upon depression. Effects on opiate receptor sensitivity were sug-
gested but were not found at the level of significance (p<.001) em-
ployed. These results were later independently reproduced using a 
50 Hz, 1.1 milliT ELF-MF [30]. In both cases, the effect resulted 
from acute (about 0.5-3 ksec) exposure.  
  Many time-varying MF appear to have the potential to influ-
ence behaviour through 5-HT, but the number of studies examining 
this possibility are few as the focus is usually upon opiates. Appli-
cation of specific and nonspecific antagonists in MF studies would 
serve to isolate the contribution of 5-HT, if any, to MF-induced 
behavioral changes.  
c. Dopamine (DA)  
  MF effects on dopamine (DA) also present strong therapeutic 
potential and are thought to occur in rTMS [55] and in the treatment 
of debilitating disorders such as Parkinson’s disease, a disorder of 
DA depletion, with ELF-MF [135, 136, 139, 142, 143]. DA modu-
lation may also play a role in the locomotor responses that occur 
with MF exposure [112]. Many effects on DA pharmacology have 
been reported which suggest that it plays a strong role in MF re-
sponses.  
  Work by Sandyk and colleagues [135, 136, 139, 142, 143] has 
repeatedly shown the ability of ultra-weak (pT) ELF-MF to amelio-
rate the symptoms of Parkinson’s disease and other disorders, such 
as Tourette's syndrome [137], in a manner consistent with improved 
DA transmission. In most cases, the D2 receptor is implicated. 
While this theory has not been verified neurochemically, MF are 
known to influence transmission at other DA receptors. With expo-
sure to a milliT range, 10 Hz MF, reduction in the reactivity of 
central D1 receptors may occur [153]. A further consequence of 
exposure to ELF-MF may be an increase in DA turnover in the 
frontal cortex [154].  
  While effects on DA production were not found in these stud-
ies, they have been noted elsewhere. In a cellular model of rTMS, 
Shaul and colleagues [148] reported a decrease in intracellular DA 
andDA precursor 3,4-dihydroxy-L-phenylalanine (L-DOPA) within 
neuroblastoma cells following application of a 3 Hz, 1.7 T MF for 
10 s. Chronic treatment or use of other frequencies (15, 20, 45 Hz) 
did not yield an effect. It should be noted that while the application 
of rTMS is remarkably similar to the application of extracranial 
ELF-MF by Sandyk, the intensity used in rTMS is greater by a 
factor of a trillion. The two effects may not necessarily be related. 
Changes in DA concentration have also been noted with in vivo
models of rTMS in the area of the dorsal hippocampus [59].  
  The DA system, in contrast to that of 5-HT, does not appear 
susceptible to power frequencies (ELF-MF of 50 or 60 Hz). While 
the intensity of the MF used in these studies varies, very low fre-
quency (< 15 Hz) and short exposure duration (< 3 ksec) appear 
common and may be critical to the induction of DA effects. The 
involvement of multiple receptor subtypes of DA with different MF 
configurations suggests a gradient of DA responses is possible. It 
should be noted that the beneficial effects found by Sandyk and 
Iacono were blocked by pre-treatment with naltrexone [143] which 
strongly suggests, as in the case of MF-induced cholinergic and 5-
HT effects, that opiate transmission is involved in their generation.  
d. Nitric Oxide  
  The discovery that pharmacological modulation of NO could be 
involved in the effects of MF [8, 25, 50, 56, 58, 87, 97, 106, 146, 
147, 174, 175] has revolutionized the field of bioelectromagnetics. 
Given the involvement of NO in a multitude of essential biological 
functions, modulating NO activity with MF has tremendous thera-
peutic potential.  
  Studies showing relationships between NO generation and MF 
exposure have accumulated rapidly over the last few years. En-
hancement of NO generation has been seen with application of mT 
range SMF for 30 min in humans [155], 60 Hz MF for 48 hr in 
mice [50] and 50 Hz MF in rats [46]. The pattern of NO production 
across the cerebrum found by Jelenkovic and colleagues in part 
resembles that of the change in the activity of the cholinergic sys-
tem demonstrated by Lai and others [66] in that it occurs within the 
frontal cortex and hippocampus. Exposure to a 0.1 milliT, 60 Hz 
MF enhanced the NO generation of lipopolysaccarides in vivo
[175]. Enhanced expression of neuronal nitric oxide synthase 
(nNOS) a subtype of the NO synthesizing enzyme nitric oxide syn-
thase (NOS) has been noted following exposure to pulsed MF [62].  
  In contrast with these findings, Noda and colleagues report 
changes in NO activity of the rat cerebellum with pulsed DC MF 
[100] but found no effect from AC or static DC MF. Positive NO 
responses have also been shown for higher frequency ranges. VHF-
MF can influence NO activation in the nasal and sinus mucosa 
[174] and NO production in the cerebellum [97]. NO responses 
appear to occur at many frequencies and intensity levels and may 
be, like modulation of opiate transmission, a general correlate of 
MF exposure. Predicting the direction of NO modulation based on 
field parameters presents a challenge to future researchers.  
  The effect sizes in these experiments were relatively strong (15-
40%) which suggests a significant relationship between NO and MF 
exposures that is not causal but involves two or more intervening 
variables. While there is strong support for a role of NO in many 
MF-induced responses, direct biomolecular connections between 
these changes, NO, and NOS subtypes have proved elusive. Addi-
tionally, it is sometimes difficult to relate biochemical changes 
directly to the behavioral effects of MF exposures.  
III. INTERACTIONS BETWEEN ELF AND DRUGS  
a. Extremely Low Frequency Field (ELF) Interactions with 
Drugs  
  Following public concerns about the health risks of AC power 
transmission, which utilizes 50 Hz in Europe and 60 Hz in North 
America, there has been continual research into the effects of power 
frequency fields on biology and behaviour [31, 116]. The ubiquity 
of power frequency fields mandates comprehensive investigation 
into their safety; accordingly research concerning the adverse bio-
logical effects of power frequency MF is a broad field and consti-
tutes the core of contemporary MF research in North America and 
Europe.  
  While power frequency fields are known to have replicable 
effects on human biology and behaviour [18, 51, 152], other ELF-
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overlooked. Square-wave 0.5 Hz [87, 101], 1 Hz [8], and 7 Hz [63, 
111] MF, among others, are known to be effective in the experi-
mental setting. Complex MF, which incorporate many different 
frequencies per complete pulse, have diverse effects and have been 
shown to effect hippocampal cell morphology [157] and prenatal 
development [87, 91]. MF modeled after the oscillations of endoge-
nous processes and geomagnetic events are an emerging trend in 
laboratory research. These "rationally designed" MF are thought to 
influence biological systems of matched frequency [87]. While 
ELF-MF and MF in general may not have carcinogenic influences 
on their own, they may interact with carcinogenic agents [81].  
  Most investigations into the interaction between ELF-MF and 
drugs focus on enhancing the pharmacological treatment of pain. 
NO modulation is one route being investigated as there are multiple 
synergies between NO modulators and these fields. NO-releasing 
agents such as s-nitro-n-acetylpenicillamide (SNP) may potentiate 
the hyperalgesia induced by 60 Hz fields in Cepaea nemoralis
while nonspecific NO inhibitors such as NG-nitro-l-arginine methyl 
ester (L-NAME) may suppress it [56]. It is noteworthy that these 
NO-modulating agents had no effect without MF. In contrast, 
Dixon and Persinger [25] found that co-administration of L-NAME 
and amygdaloid-simulated, burst-firing MF counteracted the anal-
gesic effects of morphine on hotplate analgesia. As the influence of 
MF on analgesia is bidirectional and variable depending upon the 
experiment, the effect of NO modulation is not always consistent.  
  Adrenergic receptors may be relevant to ELF-MF-induced an-
algesia as they can influence the effects of opiate-mediated analge-
sia [85]. In their experiment, Martin and Persinger demonstrated the 
ability of central alpha2 adrenergic agonist clonidine to potentiate 
ELF-induced analgesia. No effect was noted for alpha1 adrenergic 
antagonist prazosin. These relationships need to be explored in 
therapeutic settings.  
  Recently, synergies with clonidine were found to exist for other 
behaviours. Potentiation of clonidine-induced sleep in 2 day old 
chicks was reported for ELF-MF [96]. This increase involved 
gamma amino butyric acid subtype A (GABAA) and benzodi-
azepine receptors. Coupled with the results and Martin and Pers-
inger [85] these data show that synergies may be bidirectional in 
that MF and pharmacology have the ability to influence each 
other’s effects.  
  Benzodiazepine receptors also appear involved in the hyperal-
gesic effects of 60 Hz MF on mice [49]. In their experiment, Jeong 
and others noted that inhibition of benzodiazepine receptors with 
central competitive antagonist flumazenil abolished the hyperalge-
sia effect while the application of benzodiazepine agonist diazepam 
potentiated it. In a more recent study, antagonism of benzodi-
azepine but not GABAA or GABAB receptors blocked this hyper-
algesic effect [48].  
  ELF-MF may also have important treatment value for partial 
complex (limbic) epilepsy [2] that can be tested experimentally. In 
a model of ion cyclotron resonance [78] for lithium, McKay and 
Persinger [88] showed a decrease in seizure onset time in lithium-
pilocarpine seized rats with the application of a field tuned to reso-
nate with lithium ions. The authors noted that these effects could 
also be consistent with modification of both NO or opiate transmis-
sion by MF. The ELF-MF sensitivity of lithium-pilocarpine seized 
rats given noncompetitive n-methyl-D-aspartate (NMDA) antago-
nist ketamine post-seizure to prevent morbidity has been shown 
[90]. Rats administered ketamine (100 mg/kg) immediately after the 
induction of the lithium-pilocarpine seizures, who are otherwise 
similar to non-seized controls [169], performed abnormally on a 
radial arm maze task only when they were exposed to complex, 
physiologically-patterned magnetic fields with intensities between 7 
nT and 500 nT. The latent behavioral deficits suggest a complex 
role of chemical history in the sensitivity to patterned ELF-MF.  
  Interactions between ELF-MF and addictive psychoactive sub-
stances also exist. In two related experiments, the ability of these 
fields to influence cocaine response was shown. In one case, a 60 
Hz, 2 milliT MF was found to potentiate the lethal effects of co-
caine while in another a 4 Hz, 2 milliT field was found to influence 
the seizures and premorbid behaviours induced by cocaine [61]. 
Further, 50 Hz MF have been shown to blunt the locomotor re-
sponse to amphetamine with prolonged exposures [42]. Moderate 
but not low or high doses of ampethamine also appear to interact 
with this configuration [112]. In these experiments, catecholamine 
involvement was strongly suspected and exposure period was a 
critical factor.  
  The aforementioned treatment of Parkinson's disease with ELF-
MF is another promising application for a disease that may be co-
promoted by environmental exposures to neurotoxins. Sandyk has 
found that application of a complex patterned, 7.5 picoT MF field 
with a median frequency in the 2 Hz range suppressed the side ef-
fects of Parkinson medication levodopa. He hypothesized this oc-
curred through melatonin- or opiate-mediated [136, 142] mecha-
nisms. The treatments employed by Sandyk were also effective on 
their own [135] and may ultimately reduce the requirement for 
medication. The treatment of multiple sclerosis and its animal mod-
els (experimental allergic encephalomyelitis) may also be improved 
by brief but repeated, particularly nocturnal, exposures to extremely 
weak ELF-MF [63, 110].  
  Rational “tuning” of the applied ELF-MF to the intensity of the 
components of the local geomagnetic field, based upon models of 
physical resonance, may be essential for “opening the gateways” 
formaximumsynergisms.Dailyexposures to a theta burst-patterned, 
200 to 500 nanoT, MF presented once every 4 s markedly enhanced 
rats’ capacities to discern a local static anomaly (185 microT) su-
perimposed upon a mean background of 57 microT (SD=23 mi-
croT). The congruence was based upon a theory of “progressive 
polynomial resonance.” Vorobyov [171] found that rats exposed to 
a more traditional Ca
2+-tuned static/time-varying field at 20.9 mi-
croT with a 48 Hz (the third harmonic of the cyclotron 16-Hz fre-
quency) variation displayed increases in electroencephalographic 
power within the central frequencies of about 6 Hz, 10 Hz, 14 Hz, 
and 16 Hz. Injection of morphine (10 mg/kg) combined with MF 
produced marked changes in the profile compared to those evoked 
by morphine alone. The MF eliminated the effect of intracebroven-
tricular morphine at 2 Hz, decreased the power in the 6.6 Hz to 7.5 
Hz band and increased the power within the 12.3 Hz to 20.3 Hz 
band. Further, the MF interacted powerfully with intraperitoneal 
morphine injection. 
b. Extremely High Frequency Field (VHF) Interactions with 
Drugs  
  Since the advent of communications technology utilizing VHF 
(MHz-GHz range) there have been many investigations into bio-
logical consequences of VHF exposure. Microwave cooking appli-
ances, radar, and mobile communications devices are among the 
most prevalent of technologies associated with MW frequencies 
(300 MHz-300 GHz). A wide spectrum of biological and behavioral 
effects [20, 21, 43] have resulted from MW exposure; these effects 
are thought to be short-term and of rapid onset. While many posi-
tive effects have been reported, their replication has encountered 
difficulty. For example, the early results of Lai, Horita and Guy 
[75] showed an affect of MW on radial maze behaviour, but later 
work by Cobb and colleagues [16] and Cassel and colleagues [11] 
utilizing relatively slight differences in method did not.  
  In several cases, VHF-MF have been shown to operate in syn-
ergy with drugs. In one of the earliest investigations into drug-MW 
interactions, Thomas, Burch and Yeandle [163] showed a potentia-
tion of the effect of anxiolytic chlordiazepoxide (at clinical dos-
ages) on fixed interval behaviour for food reinforcement by a 2.8 282    Current Neuropharmacology, 2007, Vol. 5, No. 4 Whissell and Persinger 
GHz, 1 mW/cm
2 pulsed MW. On its own, the MW was ineffective. 
This relationship between MW and drug efficacy could not be ex-
tended to other anxiolytics such as diazepam or chlorpromazine 
[164]. While it is unlikely that chlorpromazine interacts with MW 
to affect fixed interval behaviour, it does influence the hyperther-
mia induced by stronger (60 mW/cm
2) MW [44]. As these MW 
patterns are scarcely encountered, they do not pose an occupational 
hazard but are of interest in understanding the mechanisms by 
which MW influences the biological system.  
  Drug-MW synergies have also been shown to work in reverse, 
with MW exposure enhancing the effect of normally inefficient 
drugs. Quock, Kouchich, Ishii and Lange [120] showed that co-
administration of the antidopaminergic agent domperidone and MW 
at 2.45 GHz, 20 mW/cm
2 for 10 min could counteract the effects of 
DA agonist apomorphine on stereotypic climbing behaviour in 
mice. Neither the drug nor the MW in isolation had an effect on 
climbing behaviour. In earlier experiments, the ability of applied 
MW to facilitate methylatropine antagonism of the chlolimimetic 
drug effects by muscarinic acetylcholine agonists pilocarpine and 
oxytremorine [118] was noted even though methylatropine alone 
had little effect.  
  Just as the parameters of the MW strongly influence the out-
come of drug-MW experiments, so too can the parameters of the 
drug regime. In later work with chlordiazepoxide, Quock, Klauen-
berg, Hurt and Merritt [119] found that selective interactions ex-
isted between the applied drug and MW treatment. In their experi-
ment, only acute exposure to very high frequency, very strong MW 
(4.7 GHz, 36 W/kg, applied for 300 sec) counteracted the effects of 
chlordiazepoxide on rearing and steps ascended in the mouse stair-
case test.  
  MW have potent interactions with other clinically relevant 
drugs. In the first of a series of experiments, Lai and colleagues 
showed the ability of acute exposure to 2.45 GHz pulsed waves of 
between 3-6 mW/cm
2 to influence the stereotypy and thermal re-
sponses induced in rats by psychoactive compounds [73]. MW 
pulses of this configuration were shown to enhance apomorphine-
mediated hyperthermia and stereotypy and attenuate amphetamine-
induced hyperthermia. Other effects were found when chlorpromaz-
ine and 5.6 GHz EM were applied [45]. Exacerbation of morphine-
induced catalepsy and lethality was also seen with MW treatment at 
certain dosages of the drug. Modulated VHF-MF are known to 
potentiate the hypnogenic effect of hexenal and may lower the re-
quired dose of haloperidol to induce catalepsy. Lasting effects on 
haloperidol were found 24h after exposure in the open field test 
[149].  
  Lai and others have also shown that their MW pattern can in-
fluence the rate of but not the final level of the hypothermic re-
sponse to injected ethanol [74]. Consumption of an ethanol-fluid 
solution after exposure was also found to be effected by the com-
bined treatment. Other experiments have shown an ability of etha-
nol to attenuate MW-induced changes in blood brain barrier perme-
ability [99] which were found to be short-term responses to acute 
exposure only [39]. The results obtained by Cosquer and others [19] 
show no effect of MW on scopolamine methylbromide administra-
tion and suggest the likelihood of a universal increase in blood 
brain barrier permeability to all substances is low.  
  Ultra-wide band radiation emitted by technology (UWB) is also 
of concern, but the recency and scarcity of it has left little room for 
investigation. While only mild behavioral deficits arise from UWB 
exposure during development [17] few interactions with medication 
have been examined. It is known that UWB has no effect on penty-
lenetetrazol induced convulsions and does not appear to possess 
anticonvulsant properties [95]. Acute UWB can reduce the hyperac-
tivity induced by nitric oxide synthase inhibitors in mice [146] but 
seems to have little effect on nociception [145, 146]. No interac-
tions with morphine were found [145] which is surprising given the 
results found with MW and other VHF-MF and suggests UWB may 
exert its influence through different mechanisms.  
c. Static Magnetic Field (SMF) Interactions with Drugs  
  The biological effects of SMF have always been of interest but 
became a serious concern when use of Magnetic Resonance Imag-
ing (MRI) technology in diagnosis became common. The intensity 
to which the individual is exposed in an MRI is many thousands of 
times stronger (1 T to 5 T) then that for incidental ELF exposures. 
Most SMF studies use intensities within this range. The physical 
properties of these SMF are likewise considerably different from 
both ELF- and VHF-MF. While MRI technology appears safe and 
the influence of even intense SMF is weak, there are several studies 
which suggest strong, potentially negative effects and there is a 
need for replication of these positive findings [12, 24, 144]. Com-
plex interactions may also occur between SMF and time-varying 
fields in the environment [176, 177].  
  Compared to the body of literature supporting ELF- and VHF-
MF drug interactions, investigations examining the effects of SMF 
on drugs are scarce. Research into the potential of strong SMF to 
increase effectiveness of anti-cancer drugs, particularly in cell lines, 
is a notable exception [13, 107, 108, 165]. A review of the role of 
SMF in anti-cancer therapy is presented by Gray, Frith and Parker 
[38]. The effect of SMF on medication of epilepsy [93] and modu-
lation of vasculature [36, 102-106] comprise the remaining portion 
of SMF-drug studies.  
  The interactions between SMF and other drugs, such as psycho-
tropics, have received little attention in recent literature, but have 
been reported. Kholodov and others [60] reported very specific 
synergisms between pharmacological agents and a 50 milliT hori-
zontal SMF that by itself produced a three fold increase in the per-
centage of spindles and slow waves within the hypothalamus, sen-
sorimotor cortices, thalamus, caudate, midbrain reticular system 
and hippocampus of rabbits. Intravenous adrenaline (.03 mg/kg) 
produced a marked increase in this response while the sedative 
nembutal (13 mg/kg) and the antipsychotic aminasine (12 mg/kg) 
sharply decreased the response. The direct effect of the SMF on the 
brain was supported by the absence of this electrophysiological 
response when the posterior ventrolateral thalamus or posterior 
hypothalamus was lesioned prior to exposure. Lesion of the cere-
bral cortices had no effect.  
  Effects of SMF on pharmacological modulation of vasculature 
are well described and have much potential. Recently, Gmitrov and 
Ohkubo [36] showed an ability of the Ca
2+ channel blocker vera-
pamil to reverse 0.35 T SMF-induced increases in baroflex receptor 
sensitivity. Their study also showed that verapamil could reverse 
the decreases in baroflex receptor sensitivity caused by geomag-
netic disturbances. Their variations are within the mHz range with 
peak-to- peak variations primarily between 20 nT (a frequent bioef-
fective threshold) and several 100 nT over durations of 1 ksec to 
100 ksec. Other agents acting on calcium channels have similar 
synergies with drugs. The vascular effects of 2 mg/kg L-type Ca
2+
channel blocker nicardipine were also potentiated by an mT range 
SMF [105, 106] even though the SMF was not very effective alone 
[105]. SMF have also been shown to reverse norepinephrine-
mediated increases in blood pressure [102-104]. The ability of 
clinically silent fields to reverse the effects of L-NAME on vascula-
ture is also known [103].  
  Interactions with epilepsy medication also exist but are only 
beginning to be uncovered. The potential anticonvulsant properties 
of SMF may also interact with phenytoin [93] to reduce audiogenic 
seizures in DBA/2 mice. The effects of both SMF and ELF-MF in 
seizure models suggest tuned MF may non-invasively enhance 
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IV. MECHANISMS AND PROCESSES  
  The general pattern of results that emerges from this review is 
that MF affect opiate, cholinergic, serotonergic and dopaminergic 
systems as well as the gaseous neurotransmitter nitric oxide. How-
ever, there are two limitations of this summary. First, the systems 
studied are more likely to reflect convenience rather than concept as 
well as the contemporary consensus among researchers. Second, the 
generalization that "magnetic fields affect cholinergic pathways" is 
likely to be as over-inclusive as the statement "drugs affect cho-
linergic pathways". In the latter case, without specifying the spe-
cific structure of the drug, its dosage, its route of administration, 
and perhaps even its vehicle, generalized statements are meaning-
less. Analogously, multiple parameters of an MF determine its ef-
fect, mechanism, and interaction, if any, with pharmacological sys-
tems.  
  Electromagnetism is the only natural force that can affect mat-
ter at the various levels of discourse that have been arbitrarily de-
fined by scientific inquiry. Consequently the application of appro-
priately patterned MF can produce changes in behaviour, organ 
weights, tissue activity, cellular function, molecular reactions, and 
even the characteristics of the electron and proton chains involved 
with these reactions [1]. This multi-leveled impact will ultimately 
allow an independent reference point by which the levels of scien-
tific discourse are interrelated and could either replace or certainly 
supplement the contemporary model of linear reductionism. By 
observing the changes evoked by the same applied MF within dif-
ferent levels of discourse perhaps a rational equivalence of response 
can be discerned that would allow the "translation" of an effect 
within molecular signaling pathways to, for example, behavioral 
alterations.  
  This multiplicity of potential responses might explain, more 
than discipline-specific models of the phenomenon, a rationale for 
why many hypotheses for MF effects may be equally correct but 
only valid within their own particular level of space. Given the 
complexity of living systems and the parallel processing that is 
evident, particularly within the multitude of neurotransmitter sys-
tems, there may be a myriad of physical changes within the levels 
of discourse that respond to MF. The pursuit of a singular mecha-
nism may be as elusive as attempting to explain a phenomenon that 
is defined only by a multiple regression equation containing a 
dozen independent variables with diminishing partial regression 
coefficients, with a single bivariate plot.  
  The effect sizes of MF treatments, that is the amount of vari-
ance in the dependent variable explained or accommodated by the 
treatment, are within the range of 10% to 20% for most neuro-
chemical studies. This low magnitude suggests the powerful role of 
other mediating variables or the effect of MF upon only a subset of 
molecules within "the same" pathways. Considering the conse-
quences of realizing the existence of isoenzymes, isomers, and elec-
tron subpopulations upon neuropharmacology, the assumption that 
an applied magnetic field affects all molecules of the same species 
"identically" may not be valid. On the other hand the effect sizes for 
most of the analgesia studies involving the whole organism and the 
interactions shown in MF-drug studies are often within the range of 
40% to 50%. This strength suggests a closer causal proximity to the 
temporal-spatial processes that produced the effect. In all of these 
studies, however, the effect sizes seldom approach 90%, the size 
typical of ligand-receptor binding effects or other physicochemical 
reactions in which there is a linear causal connection between the 
stimulus and the response. The role of the individual may also be 
important; the possibility that individual hypersensitivity to MF 
may exist, in a manner similar to allergies for certain proteins, as an 
explanation for this variability [83] is under investigation.  
  Mechanisms by which MF effect living systems, and hence 
through which pharmacological agents could interact, have focused 
upon variants of Faraday's Law, in that "a changing magnetic field 
is associated with a changing electric field." Five of the most likely 
electric, magnetic or synergistic mechanisms to examine the nature 
of magnetic field transduction in biological systems have been pro-
posed [29] and each has its own support within the literature. Other 
notable models exist [32] which explain the replicable effects of 
MF on cellular physiology [4, 125, 128, 150, 178], particularly the 
dynamic interactions with blood flow and microvasculature [92].  
  Usually mechanisms are based upon the temporal symmetry 
(either sinusoidal waves or square waves, for example) of the ap-
plied MF. The classic arguments against weak (< 1 microT) MF 
affecting cells are usually derived from the argument that the ener-
gies involved would not be sufficient to compensate for random 
thermal agitation (the Boltzman "boundary"). Similarly, theoretical 
arguments have been published against the effects of VHF-MF on 
the organism at low incident power densities (< 15 mW/cm
2), yet 
many studies demonstrate positive effects at this range. The contin-
ued demonstration of subtle yet significant behavioral and neuro-
chemical changes in spite of these theoretical impossibilities sug-
gests that current models may be inadequate.  
  Sensitivity to small variations in geomagnetic activity and 
shielding from the geomagnetic field [22] are known to effect be-
haviour in animals, possibly because they evolved within this envi-
ronment. The wave amplitudes produced by geomagnetic phenom-
ena, such as micropulsations, and atmospheric phenomena, such as 
whistlers and spherics can be shown to induce inside cells currents 
of the same magnitude (1-30 pA) as the currents generated by the 
cells themselves [27]. Even conservative estimates [33] show that a 
1 microV induced membrane potential can be detected after 10 
msec by an ensemble of less than 10
8 ion channels. Liboff and oth-
ers [77, 79] showed the threshold intensity to affect DNA synthesis 
by a wide range of sinusoidal MF (15 Hz to 4 kHz). The effect, 
which was maximum during the middle of the S-phase of the cell 
cycle, was independent of the time derivative and suggested a 
mechanism other than Faraday's Law.  
  The concept of MF effects being enhanced by the temporal 
congruence between the applied MF and intrinsic variations of the 
target molecule, cell, cell aggregate, or even the organism assumes 
strong magnetic fields are not required. According to Persinger 
[110], Jacobson [40, 41] and Sandyk [137] even pT to nT magnetic 
fields are effective with appropriate resonance as a function of the 
mass of the target molecule. There is strong mathematical evidence 
that MF absorption can occur in stochastic cellular systems through 
enhanced detection in ion channels and by calcium oscillators 
[134].  
  That MF ultimately affect ions would accommodate for the 
diffuse nature of their reported effects across levels of scientific 
discourse. For example, if Ca
2+ ions are primarily affected, as first 
hypothesized by Ludwig [82], and later verified by Adey and others 
[1,7], then this modification percolated through larger and larger 
organismic space could explain the positive effects of magnetic 
fields upon reducing depression [5] due to alterations in Ca
2+ sig-
naling [173]. Voltage gated Ca
2+ L-type channels have been shown 
to mediate the stimulation of neurite growth in cultured chromaffin 
cells by 60 Hz (0.6 milliT) fields because the blocker nifedipine 
eliminated this response [98]. These channels may play in a role 
MF-induced analgesia [57] and vascular changes [105, 106] and 
may facilitate absorption of EM and its information by stochastic 
processes [134].  
  As mentioned previously, reconciling MF-induced variations in 
NO activity with the sequelae of MF exposure is difficult. The dif-
fuse pattern of activation might suggest a cascade of intracellular 
events with the intermediate participation of ions such as Ca
2+ and 
their associated cellular machinery. However, there will be a need 
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ables. The characterization of the role of these in the generation of 
MF responses requires a comprehensive body of literature that al-
lows for comparison of the role of these variables in MF responses 
at different chronological intervals.  
V. IMPLICATIONS  
  The observation that weak physiologically patterned MF can 
interact with the effects of pharmacological agents to alter or to 
significantly increase the potency of pharmacotherapy has powerful 
implications for this century. As the usage of both pharmacological 
agents and electromagnetic fields for communication systems and 
appliances increases within Western civilization, synergistic inter-
actions must occur. In several studies the interaction between inten-
sities of pulsed or physiologically-patterned MF potentially present 
within the environment and frequently employed pharmacological 
agents such as clonidine [85] and chlorodiazepoxide [163] pro-
duced effects that were several magnitudes greater than those from 
the application of simply the drug itself.  
  If MF-drug synergisms are as specific as the simple sequester-
ing found between ligands and high affinity receptor subtypes, then 
weak (1 microT, at 42.5 Hz for the proton) and very, very weak (1 
nT, at 28 Hz for the electron), appropriately patterned MF could 
produce unanticipated exacerbations of neuropharmacological re-
sponses. The presence of these interactions, and the inability to 
resolve them mechanistically, reflects a need for an integrated, in-
terdisciplinary approach in future bioelectromagnetics research. 
Pharmacology has yet to apply the models of quantum mechanics 
and fine-structure electromagnetism to drug effects. For example, 
NO, which is involved in a multitude of MF responses, is also the 
only free molecule whose magnetic susceptibility does not conform 
to the "spin-only" formula. NO is a classic example of a molecule 
that deviates from Curie's Law because the multiplets of the atomic 
spectra interval are comparable with the kT boundary [170]. Elicita-
tion of quantum phenomena by hereto unexpected synergisms be-
tween "routine" pharmacological agents and specifically designed 
magnetic patterns could result in macroscopic changes with emer-
gent properties with unanticipated potency.  
  The employment of patterned magnetic fields to discern the 
presence of pharmacological compounds has numerous applica-
tions. One historical example in neuropharmacology was the dis-
play of conspicuous vascular and visceral responses to disulfiram if 
the person's blood level contained ethanol but no response if there 
was no ethanol. A similar synergism may exist with magnetic 
fields. Many years ago, Kholodov [60] showed that static magnetic 
fields could not be detected by the average person. However during 
states of hypnosis, or after consumption of mescaline, modifications 
of the visual images seen by volunteers when MF were applied 
could be clearly discerned. Persinger [109] reported that during 
casual intoxication by Lysergic Acid Diethylamide (LSD-25) par-
ticipants reliably reported specific colors emerging around rotating 
MF within a completely darkened room. These "colors" were not 
reported when the field was present but the subjects had not con-
sumed LSD. Such reactions, while not intensively studied, point to 
possible influences of MF on psychotropic drug states yet to be 
characterized [133].  
  The understanding of neuropharmacological synergisms with 
MF within the brain also requires a greater empirical understanding 
of the specific, endogenous temporal patterns of electrophysiologi-
cal activity. Specific changes in the temporal pattern of effective 
stimuli that produce long term potential (LTP), a phenomenon once 
considered to be relatively homogenous, vary across different layers 
of the entorhinal cortices in the rat [159]. This suggests that appro-
priately patterned MF may maximally interact with pharmacologi-
cal reactions only in those brain volumes that contain resonant pat-
terns. As well as different molecules being effected by MF, differ-
ent regions may be effected as well.  
  There are two discrete brain regions within which pharmacol-
ogical agents and physiologically-patterned MF might interact. The 
first is the pineal organ which contains the synthesizing enzymes 
for melatonin as well as copious concentrations of Ca
2+ both of 
which can be affected by MF whose frequencies coincide with the 
ion's resonance [76]. The precise afferent neuroanatomy of this 
gland in the human is still not clear, as indicated by the recent re-
port [156] of a new paired tract that can be traced to the pretectal 
area. The role of the pineal gland in MF responses may be strongly 
affected by the species studied [126, 127, 166].  
  The second area involves the hippocampus and limbic system. 
This region of the brain, in conjunction with the amygdala, shows a 
lower threshold for paroxysmal activity than any other structure. 
The neurons located within this area are prone to phase coupling 
[172] and amplification with large volumes of the entire structure. 
Additionally, the hippocampal formation contains magnetite and 
related magnetic material sufficient to allow epileptiform activity to 
be evoked in epileptic patients by applied magnetic fields of only 1 
milliT [26] Altered brain metabolism of iron has been considered a 
significant contributor to neurodegenerative diseases because the 
release of iron ions from injured brain cells stimulates free radical 
reactions [35]. Pharmacological compounds that modulate the func-
tional susceptibility of these substances, which can exist in concen-
trations greater than pg/g of tissue, might contribute to significant 
synergisms.  
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